Equinor (OSE:EQNR, NYSE:EQNR) delivered adjusted operating income* of USD 7.90 billion and USD 2.29 billion after tax in the ...

Shree Cement, Coromandel International, Dr Lal PathLabs share prices will remain in focus as will traded trade ex-date today.

Bridgewater Associates' flagship fund Pure Alpha posted a gain of 8.2% in January, in a period when investors navigated a ...

Healthcare stocks have jumped, but the easy money has already been made. The ETF, home to health insurers, drugmakers, and ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

On Monday, Kay & Que (Bangladesh), a publicly listed company, was also downgraded to the Z category for the same reason.

Regeneron beat Q4 estimates with $12.07 EPS and $3.79B in sales. The company announced a dividend, a $3 billion buyback, and continued R&D investments.

Aspiring retirees spend many years saving up money so they have a large enough nest egg for retirement. It’s common for young ...

Inflation, uncertain markets and a limited Social Security COLA are among the financial hurdles for retirees in 2025.

With a cost of $0 for this AI tech, the reasoning goes, there’s no reason to spend billions on AI from companies like OpenAI ...

DUBLIN, Ga., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Morris State Bancshares, Inc. (OTCQX: MBLU) (the “Company”), the parent of Morris Bank (the “Bank”), today reported its financial results for the quarter ...

(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback ...